Alternatives to Randomized Premarket Studies presented by Laura Mauri, MD at CRT 2015
Session Name: Session III: What Are the Challenges and Potential Solutions to Meeting Clinical Data Requirements for Premarket Approval (PMA), Post-Market Surveillance and Reimbursement?
Track: Technology & Innovation